Intracardiac Thrombosis in A Neonate: A Case Report | ||
| Journal of Integrated Maternal and Pediatric Care | ||
| Volume 4, Issue 1, June 2021, Pages 65-69 PDF (360.98 K) | ||
| Document Type: Case Report | ||
| DOI: 10.18502/wjpn.v4i1.7547 | ||
| Authors | ||
| Seyed Reza Mirjalili1, 2; Morteza Danaeian1; Fatemeh Baghalsafa* 2 | ||
| 1Department of Pediatrics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | ||
| 2Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | ||
| Abstract | ||
| Background: Life-threatening intracardiac thrombosis is rare. Intracardiac thrombosis may affect neonates from the first months of life. Because of the potential risk of serious bleeding, the use of recombinant plasminogen activator (rt-PA) in neonates along with heparin is controversial. Case Report: We reported a 37- day- old term infant presented with fever, restlessness, malaise, and respiratory acidosis. Right atrial thrombose was identified by ECHO, results of laboratory tests, and examination. She was successfully treated with rt-PA and rivaroxaban. Conclusion: Early echocardiographic detection before the clot grows large and organized, allows complete, safe, and rapid thrombolysis with rt-PA and rivaroxaban. | ||
| Keywords | ||
| Thrombosis; Neonate; Recombinant tissue plasminogen; Rivaroxaban | ||
| References | ||
|
| ||
|
Statistics Article View: 386 PDF Download: 244 |
||